Showing results (71-80 of 192) with videos related to
Sort By:
Pageof 20
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 15, 2026
Investigating the Association Between Cystic Fibrosis and Colorectal Neoplasia: A Matched Case-Control StudyDazhong Huang, Douglas Tjandra, Ammar Majeed, et al.Advances in Nutrition (Bethesda, Md.)|February 14, 2018
Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in AdultsElena S George, Adrienne Forsyth, Catherine Itsiopoulos, et al.Journal of Gastroenterology and Hepatology|February 13, 2020
Nonalcoholic fatty liver disease burden: Australia, 2019-2030Leon A Adams, Stuart K Roberts, Simone I Strasser, et al.Journal of Gastroenterology and Hepatology|February 8, 2006
Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis CAdam Gordon, Daryl A Hobbs, D Scott Bowden, et al.Plos One|November 13, 2015
The Cascade of Care for an Australian Community-Based Hepatitis C Treatment ServiceAmanda J Wade, Diana M Macdonald, Joseph S Doyle, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2026
Non-Invasive Prediction of Decompensation in Compensated Advanced Chronic Liver Disease and a Liver Stiffness from 15 to 25 kPaAngus W Jeffrey, Avik Majumdar, Gary Jeffrey, et al.Clinics and Research in Hepatology and Gastroenterology|July 15, 2025
Steatosis non-invasive tests accurately predict metabolic dysfunction-associated steatotic liver disease, while fibrosis non-invasive tests fall short: Validation in U.S. adult populationAyesha Sualeheen, Sze-Yen Tan, Robin M Daly, et al.Hepatology International|July 15, 2024
NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional AustraliaKarl Vaz, William Kemp, Ammar Majeed, et al.Hepatology International|December 14, 2024
MAFLD but not MASLD increases risk of all-cause mortality in regional Australia, with components of metabolic syndrome exacerbating factors: 20 year longitudinal, cohort studyKarl Vaz, William Kemp, Ammar Majeed, et al.Journal of Gastroenterology and Hepatology|August 12, 2023
Non-alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyleKarl Vaz, William Kemp, Ammar Majeed, et al.Pageof 20